awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33509626-D5FD99B8-94B6-4560-9449-9E7580B777D8
Q33509626-D5FD99B8-94B6-4560-9449-9E7580B777D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33509626-D5FD99B8-94B6-4560-9449-9E7580B777D8
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology.
P2860
Q33509626-D5FD99B8-94B6-4560-9449-9E7580B777D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33509626-D5FD99B8-94B6-4560-9449-9E7580B777D8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5279b07394bd552c7e53a86d19594631394de371
P2860
Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.